Novartis AG’s drug Gilenia has risks that may outweigh its benefit in treating multiple sclerosis, according to U.S. regulators reviewing whether to approve the first pill to slow progression of the disease.
More...
More...
Our valued sponsor
Novartis’ Multiple Sclerosis Pill Faces FDA Review (Update1)
- Thread starter guest
- Start date
Latest Threads
-
-
-
Is there a was to contact Wise once they closed your account?
- Started by Sean Restling
- Replies: 2
-
EMI recommendation for Stripe Payouts 2023 (Card, IBAN, Personal Account)
- Started by EternalRecurrence
- Replies: 1
-
-
Residency reporting rules between countries for a expat?
- Started by FREE CITIZEN
- Replies: 2
-
Forming a new USA LLC before the new CTA rules apply?
- Started by FREE CITIZEN
- Replies: 5
-
-
-
UK Gov on a war path to find funds sloshed down the back of the sofa.
- Started by wellington
- Replies: 5
